Please select the option that best describes you:

How do you manage anticoagulation bridging for outpatient ESKD patients given concerns for bleeding risk with enoxaparin in this population?  

Would you bridge with enoxaparin 0.7 mg/kg/day in an ESKD patient, as described in a previous retrospective study (Pon et al., PMID: 24718051)?



Answer from: at Academic Institution
Comments
at Lankenau Heart Group
Mechanical mitral valve on hemodialysis...
Sign in or Register to read more